Svilen Konov has a degree from the London School of Hygiene and Tropical Medicine. He has worked as a clinical trials methodologist on drug development, predominantly in the field of HIV and HCV as well as concomitant diseases, with large pharmaceutical companies and has developed research protocols and analysis plans. He has experience working with the EU regulator, the European Medicines Agency (EMA) on drug approval. In addition. Svilen worked with the World Health Organization on Emergency Medical Services (EMS).

Hani Kim is the Executive Director of the RIGHT (Research Investment in Global Health Technology) Foundation. She completed her PhD in Lab Medicine and Pathobiology at the University of Toronto, Canada, her post-doctoral training in molecular immunology at the Max-Planck Institute of Immunology, Germany, and her MPH at the Johns Hopkins School of Public Health, U.S.A. Before joining the RIGHT Foundation, Hani worked as a Program Officer at the Bill & Melinda Gates Foundation, and as a Research Associate at the Johns Hopkins School of Public Health.

Dr.

With a background in veterinary medicine, Soawapak Hinjoy graduated with a doctorate in Public Health from the Johns Hopkins Bloomberg School of Public Health. Currently, she holds the position of Director of the Office of International Cooperation, Department of Disease Control, Ministry of Public Health. Enthusiastic about developing collaborations in public health research on zoonotic diseases, and emerging, and re-emerging infectious diseases under a conceptual One Health framework, she is active both in Thailand and at the international level.

Dr Veasnakiry has worked in the public health sector for 34 years. He was an assistant surgeon in a national hospital from 1989 to 1993 and then moved to work at the Department of Planning & Health Information, the Ministry of Health.